Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer

International Journal of Cancer

Volumn 97, Issue 3, 2002, Pages 272-277

  Kikuchi, Takefumi ^a,b   Itoh, Fumio ^a   Toyota, Minoru ^a   Suzuki, Hiromu ^a   Yamamoto, Hiroyuki ^a   Fujita, Masahiro ^b   Hosokawa, Masao ^b   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b Keiyukai Sapporo Hospital   (Japan)

Author keywords

Chromatin, hisrone acetylation; Methylator phenotype; NSAID

Indexed keywords

5 DEOXY 2' AZACYTIDINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTIDINE DERIVATIVE; HISTONE; TRICHOSTATIN A; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CPG ISLAND; DEACETYLATION; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STOMACH CANCER;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; AZACITIDINE; CYCLOOXYGENASE 2; CYTOSINE; DNA; DNA METHYLATION; ENZYME INHIBITORS; GASTRIC MUCOSA; GENE SILENCING; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; METHYLATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; SULFITES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0037137871     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1612     Document Type: Article

References (35)

1. The role of cyclooxygenases in inflammation, cancer and development
2. Cyclooxygenase-2 expression in human esophageal carcinoma
3. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
4. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
5. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma
6. Expression of cyclooxygenase-2 in human gastric carcinoma
7. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
8. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
9. Aspirin use and potential mechanisms for colorectal cancer prevention
10. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
11. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non- steroidal anti-inflammatory drug NS-398
12. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway
13. Transforming growth factor-beta 1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA
14. Inhibition of cyclooxygenase-2 gene expression by p53
15. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers
16. Reduced COX-2 protein in colorectal cancer with defective mismatch repair
17. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability
18. Cancer epigenetics comes of age
19. Alterations in DNA methylation: A fundamental aspect of neoplasia
20. CpG island methylator phenotype in colorectal cancer
21. Methylation-induced repression-belts, braces and chromatin
22. High sensitivity mapping of methylated cytosines
23. COBRA: A sensitive and quantitative DNA methylation assay
24. Quantitative DNA methylation analysis by fluorescent polymerase chain reaction single-strand conformation polymorphism using an automated DNA sequencer
25. Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays
26. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras- transformed rat intestinal epithelial cells
27. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB
28. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin
29. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1
30. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
31. Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines
32. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
33. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors
34. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression
35. Sequence-specific DNA binding activity of RNA helicase A to the pl6INK4a promoter